3Fukujima MM, Martinez TL, Pinto LE, etal. Fibrinogen as independent risk factor for ischemic stroke [J]. Arq Neuropsiquiatr, 1997; 55(4): 737
4Tribouilloy C, Peltier M, Colas L, et al. Fibrinogen is an independent marker for thoracic aortic atherosclerosis [J]. Am J Cardiol, 1998; 81(3): 321
5Naito M. Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells [J]. Nippon Ronen Igakkai Zasshi, 2000; 37(6) :458
6Naito M, Hayashi T, Iguchi A. New approaches to the prevention of atherosclerosis [J]. Drugs, 1995; 50(3) :440
7Mauriello A, Sangiorgi G, Palmieri G, et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks [J]. Circulation, 2000; 101 (7): 744
9Jacqueminet S, Hartemann-Heurtier A, Izzillo R, et al. Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors [J]. Diabetes Metab, 2005; 31(4 Pt 1): 370- 375.
10Alexandrescu VA, Hubermont G, Philips Y, etal. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner I 4 diabetic foot lesions:practice in a muhidisciplinary diabetic limb service [J]. J Endovasc Ther, 2008; 15(5) : 580- 593.
